Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Initiates Coverage On Embecta with Neutral Rating

BTIG Initiates Coverage On Embecta with Neutral Rating

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.

byBenzinga Newsdesk

September 8, 2022

1 minute read

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.

Hormel Foods Recalls Some Contaminated Planters Nuts In Five States

By Vandana Singh

May 6, 1:46 PM

Hormel Foods recalls Planters products due to listeria contamination. Details on impacted items & distribution areas.

HRL

Analyst Ratings

What 4 Analyst Ratings Have To Say About PPL

By Benzinga Insights

April 20, 10:00 AM

Within the last quarter, PPL (NYSE:PPL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PPL

Byline Bancorp Q4 EPS $0.65 Beats $0.59 Estimate

By Benzinga Newsdesk

January 26, 5:17 PM

Byline Bancorp (NYSE:BY) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 5.8 percent decrease over earnings of $0.69 per share from the same

TransCode Therapeutics Requests Withdrawal Of Registration Statement, Says Co. Has Determined Not To Pursue Sale Of Securities At This Time

By Michael Horton

February 14, 6:27 PM

-SEC Filing

RNAZ

BTIG Initiates Coverage On Embecta with Neutral Rating

Related Posts

Hormel Foods Recalls Some Contaminated Planters Nuts In Five States

What 4 Analyst Ratings Have To Say About PPL

Byline Bancorp Q4 EPS $0.65 Beats $0.59 Estimate

TransCode Therapeutics Requests Withdrawal Of Registration Statement, Says Co. Has Determined Not To Pursue Sale Of Securities At This Time